A Specific Picomolar Hybridization-Based ELISA Assay for the Determination of Phosphorothioate Oligonucleotides in Plasma and Cellular Matrices
- 813 Downloads
To develop and validate an ultrasensitive and specific hybridization-based enzyme-linked immunosorbent assay method for quantification of two phosphorothioate oligonucleotides (PS ODNs) (G3139 and GTI-2040) in biological fluids.
This assay was based on hybridization of analytes to the biotin-labeled capture ODNs followed by ligation with digoxigenin-labeled detection ODN. The bound duplex was then detected by anti-digoxigenin-alkaline phosphatase using Attophos® (Promega, Madison, WI, USA) as substrate. S1 nuclease and major factors such as the hybridization temperature, concentration of capture probe, and the use of detergent were evaluated toward assay sensitivity, selectivity, and accuracy.
The method is selective to the parent drugs with minimal cross-reactivity (<6%) with 3′-end deletion oligomers for both G3139 and GTI-2040. A linear range of 0.05 to 10 nM (r2 > 0.99) was observed for GTI-2040 in a variety of biological matrices. For both G3139 and GTI-2040, the within-day precision and accuracy values were found to be <20% and 90–110%, respectively; the between-day precision and accuracy were determined to be <20% and 90–120%. Addition of S1 nuclease combined with washing step greatly improved the assay linearity and selectivity. The utility of this assay was demonstrated by simultaneous determination of GTI-2040 in plasma and its intracellular levels in treated acute myeloid leukemia patients.
The validated hybridization enzyme-linked immunosorbent assay method is specific for quantitation of PS ODNs in biological samples to picomolar level. This method provides a powerful technique to evaluate plasma pharmacokinetics and intracellular uptake of PS ODNs in patients and shows its utility in clinical evaluations.
Key Wordshybridization–ligation ELISA intracellular drug level pharmacokinetics phosphorothioate oligonucleotides
acute myeloid leukemia
- AS ODN
area under the curve
total body clearance
steady state concentration
coefficient of variation
enzyme-linked immunosorbent assay
lower limit of quantification
limit of detection
messenger ribonucleic acid
peripheral blood mononuclear cell
- PS ODN
red blood cells
- RNase H
We acknowledge the support by NIH R21CA105879 and UO1 CA 76576.
- 7.Lee, Y., Vassilakos, A., Feng, N., Lam, V., Xie, H., Wang, H., Wang, M., Jin, H., Xiong, K., Liu, C., Wright, J., Young, A. 2003GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumorsCancer Res.6328022811PubMedGoogle Scholar
- 8.Desai, A. A., Schilsky, R. L., Young, A., Janisch, L., Stadler, W. M., Vogelzang, N. J., Cadden, S., Wright, J. A., Ratain, M. J. 2005A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumorsAnn. Oncol.16958965PubMedCrossRefGoogle Scholar
- 9.Marcucci, G., Stock, W., Dai, G., Klisovic, R. B., Liu, S., Klisovic, M. I., Blum, W., Kefauver, C., Sher, D. A., Green, M., Moran, M., Maharry, K., Novick, S., Bloomfield, C. D., Zwiebel, J. A., Larson, R. A., Grever, M. R., Chan, K. K., Byrd, J. C. 2005Phase Istudy of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activityJ. Clin. Oncol.2334043411PubMedCrossRefGoogle Scholar
- 10.Dai, G., Chan, K. K, Liu, S., Hoyt, D., Whitman, W., Klisovic, M., Shen, T., Caligiuri, M. A., Byrd, J., Grever, M., Marcucci, G. 2005Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemiaClin. Cancer Res.1129983008PubMedCrossRefGoogle Scholar
- 12.Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., Sasmor, H. M., Schleich, T., Tivel, K. L., Griffey, R. H. 1996Pharmacokinetics properties of several novel oligonucleotide analogs in miceJ. Pharmacol. Exp. Ther.277923937PubMedGoogle Scholar
- 13.Griffey, R. H., Greig, M. J., Gaus, H. J., Liu, K., Monteith, D., Winniman, M., Cummins, L. L. 1997Characterization of oligonucleotide metabolism in vivo via liquid chromatography/electrospray tandem mass spectrometry with a quadrupole ion trap mass spectrometerJ. Mass Spectrom.32305313PubMedCrossRefGoogle Scholar
- 15.Bres, J. C., Morvan, F., Lefebvre, I., Vaseur, J. J., Pompon, A., Imbach, J. L. 2001Kinetics study of the biotransformation of an oligonucleotide prodrug in ells extract by matrix-assisted laser desorption-ionization time-of-flight mass spectrometryJ. Chromatogr. B Biomed. Sci. Appl.753123130PubMedCrossRefGoogle Scholar
- 18.Raynaud, F. I., Orr, R. M., Goddard, P. M., Lacey, H. A., Lancashire, H., et al. 1997Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to miceJ. Pharmacol. Exp. Ther.281420427PubMedGoogle Scholar
- 19.Yu, R. Z., Geary, R. S., Levin, A. A. 2004Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokentic/pharmacodynamic assessments of antisense oligonucleotidesDrug Discov. Dev.7195203Google Scholar
- 20.Yu, R. Z., Baker, B., Chappell, A., Geary, R. S., Cheung, E., Levin, A. A. 2002Development of an ultrasensitive noncompetitive hybridization–ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasmaAnal. Biochem.3041925PubMedCrossRefGoogle Scholar
- 23.Serres, M., McNulty, M. J., Christensen, L., Zon, G., Findlay, J. W. 1996Development of a novel scintillation proximity competitive hybridization assay for the determination of phosphorothioate antisense oligonucleotide plasma concentrations in a toxicokinetic studyAnal. Biochem.233228233PubMedCrossRefGoogle Scholar
- 25.Brown-Augsburger, P., Yue, X. M., Lockridge, J. A., McSwiggen, J. A., Kamboj, D., Hillgren, K. M. 2004Development and validation of a sensitive, specific, and rapid hybridization-ELISA assay for determination of concentrations of a ribozyme in biological matricesJ. Pharm. Biomed. Anal.34129139PubMedCrossRefGoogle Scholar